| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
When it comes to our health, we as a society, have gone off course. Nearly 70% of us are overweight or obese. This makes us prime candidates to acquire preventable chronic diseases, which further reduce our quality of life. Given that chronic diseases...
Loretto is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Curve Health is senior care without walls. Founded in April of 2020 on a platform that`s reduced patient transfers from Skilled Nursing Facilities (SNFs) to Emergency Departments by 50%+, Curve advances connected senior care by bridging the silos that hinder healthcare delivery today; enabling physicians to remotely care for patients in SNFs, at home, in ambulances or wherever they may be. Curve combines telemedicine, a health information exchange, predictive analytics and smart billing into a single platform, resulting in higher quality care + significant return on investment, while ensuring the most seamless patient experience.
Alara is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.